Cutaneous collagenous vasculopathy: Report of first Japanese case and review of the literature

Cutaneous Collagenous Vasculopathy: A Short Case Series and Literature Review

ABSTRACT

Cutaneous collagenous vasculopathy (CCV) is a rare and idiopathic microangiopathy of superficial dermal blood vessels. There have been 75 cases described in the literature to date, not including the current report; however, given its clinical similarity to other primary telangiectasias, it is likely to be underreported and underdiagnosed. Here, we describe the clinical and histological features of 2 patients we newly diagnosed with CCV. Both generally fit the profile of prior cases and confirm previously described associations-they both are older White women, have rashes on their lower extremities, and have conditions and medications that are common among other reported cases. However, both are also somewhat atypical, as Patient 1 had symptomatic CCV and Patient 2 had a papular rash. As such, both cases broaden the spectrum of our current understanding of CCV. We also provide a comprehensive review of all published reports of CCV to date and uncover 2 previously unreported associations: one with visceral malignancy, and the other with hypothyroidism. Whether these association are coincidental is worth investigating in future studies.

Telangiectatic Macules Spreading During More Than 30 Years: A Quiz

Abstract is missing (Quiz)

Acquired diffuse telangiectasias with an unequivocal immunohistochemistry

A 56-year-old woman presented with abdominal, lumbar and thoracic livedo with 2 years of evolution, consisting of violaceous poikilodermatous patches with scattered petechiae on a base of erythema and telangiectasia, accompanied by diffuse and mild skin atrophy. Histological analysis revealed vasodilation of the superficial dermis and thickening of capillary walls, highlighted by periodic acid–Schiff stain and immunohistochemistry for collagen type IV.

Cutaneous collagenous vasculopathy in a pediatric patient

We report the case of a 13-year-old female who presented with punctate, erythematous macules coalescing into patches on the upper extremities and left thigh. A skin biopsy demonstrated dilated capillary-sized blood vessels in the papillary dermis consistent with a diagnosis of cutaneous collagenous vasculopathy (CCV). To our knowledge, this is the youngest patient to present with CCV and will represent the third pediatric case in the literature.

A Case of Cutaneous Collagenous Vasculopathy Associated with Multiple Myeloma and with Pathogenic Variant in the Glucocerebrosidase Gene

Cutaneous collagenous vasculopathy (CCV) is an extremely rare acquired microangiopathy of unknown etiology. The authors describe a case of a 68-year-old man, a carrier of a heterozygous pathogenic variant in the glucocerebrosidase (GBA) gene, who was diagnosed with CCV, revealing uncommon fibrinogen positivity in direct immunofluorescence. The patient was subsequently diagnosed with multiple myeloma. The treatment of myeloma with combined chemotherapy including bortezomib, followed by autologous stem cell transplantation, led to significant reduction of cutaneous lesions. To the best of the authors' knowledge, this is the first published case of CCV in a carrier of a pathogenic variant in the GBA gene, associated with multiple myeloma and with significant regression of CCV after the myeloma treatment. Direct immunofluorescence examination revealed uncommon fibrinogen positivity. Hypothetical causative role of bortezomib treatment was proposed regarding significant regression of CCV. This article is protected by copyright. All rights reserved.